AI models show promise in predicting heart disease risks, but lack validation

Review highlights the potential of AI models in predicting cardiovascular disease risks but emphasizes the need for independent external validation to ensure their clinical applicability.

Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing | Psychedelic Invest

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health Canada, has reached a significant milestone

November 29, 2023

New robot system used to improve treatment for debilitating eye disease

Researchers from King’s, with doctors at King’s College Hospital NHS Foundation Trust, have successfully used a new robot system to improve treatment for debilitating eye

June 12, 2024

8,000 Women a Month Got Abortion Pills Despite Bans, Restrictions in Their States

Though their states severely restrict abortion or place limits on having one through telehealth, about 8,000 women per month late last year were getting abortion

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.